T1520 |
Aliskiren hemifumarate
|
173334-58-2
|
99.7%
|
|
Aliskiren hemifumarate (CGP60536B) is an orally active nonpeptide renin inhibitor with antihypertensive activity.
|
T1942 |
DMH-1
|
1206711-16-1
|
99.7%
|
|
DMH-1 is a potent and selective BMP inhibitor.
|
T2147 |
Nilotinib monohydrochloride monohydrate
|
923288-90-8
|
99.7%
|
|
Nilotinib monohydrochloride monohydrate (Nilotinib (monohydrochloride monohydrate)) is significantly potent BCR-ABL against, is a second generation tyrosine kina...
|
T5096 |
SRT 1720
|
925434-55-5
|
99.7%
|
|
SRT 1720 is a selective activator of human SIRT1 (EC1.5: 0.16 μM) and is >230-fold less potent for SIRT2 and SIRT3.
|
T1994 |
Pictilisib
|
957054-30-7
|
99.69%
|
|
Pictilisib (GDC-0941) (GDC-0941) is a potent pan inhibitor of class I catalytic subunits of PI3K (IC50s: 3/33/3/75 nM for p110α/β/δ/γ).
|
T1952 |
MK-2206 dihydrochloride
|
1032350-13-2
|
99.69%
|
|
MK-2206 dihydrochloride (MK-2206 2HCl) is a variant Akt inhibitor that inhibits Akt1, Akt2, and Akt3 (IC50=8/12/65 nM) with orally active, highly potent and sele...
|
T6930 |
Pazopanib Hydrochloride
|
635702-64-6
|
99.69%
|
|
Pazopanib Hydrochloride (Votrient HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM...
|
T11381 |
Pictilisib dimethanesulfonate
|
957054-33-0
|
99.69%
|
|
Pictilisib dimethanesulfonate (GDC-0941 2 MeSO3H salt) is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM, with modest selectivity against p110β (11-fold) and p1...
|
T3S1068 |
Oxyresveratrol
|
29700-22-9
|
99.69%
|
|
1. Oxyresveratro can inhibit tyrosinase activity. 2. Oxyresveratro is useful to trauma models, as toxicity to glia could be beneficial by inhibiting reactive gli...
|
T20765 |
Atorvastatin
|
134523-00-5
|
99.69%
|
|
Atorvastatin is an orally active HMG-CoA reductase inhibitor that has the ability to effectively lower blood lipids by activating liver cytochrome p450 to accele...
|
T0078 |
Lapatinib
|
231277-92-2
|
99.68%
|
|
Lapatinib (GW572016) is an inhibitor of ErbB2 and EGFR (IC50=9.2/10.8 nM) with oral activity. Lapatinib has antitumor activity and can be used to treat advanced ...
|
T60604 |
XST-14
|
2607143-50-8
|
99.68%
|
|
XST-14 is a competitive and specific inhibitor of ULK1 (IC50: 26.6 nM).XST-14 blocks autophagy by inhibiting the phosphorylation of ULK1 downstream substrates.XS...
|
T6311 |
Bafetinib
|
859212-16-1
|
99.68%
|
|
Bafetinib (INNO-406) (INNO-406) is an effective and specific dual Bcr-Abl/Lyn inhibitor (IC50: 5.8/19 nM), and no inhibition of the phosphorylation of the T315I ...
|
T1590 |
Letrozole
|
112809-51-5
|
99.68%
|
|
Letrozole (CGS 20267) is an Aromatase Inhibitor. The mechanism of action of letrozole is as an Aromatase Inhibitor.
|
TMS1743 |
Salvigenin
|
19103-54-9
|
99.67%
|
|
Salvigenin is a potent hMAO-A inhibitor, has neuroprotective, antitumor and immunomodulatory effects.
|
T2301 |
SB 202190
|
152121-30-7
|
99.67%
|
|
SB 202190 (FHPI) is a p38 MAPK inhibitor that inhibits p38α and p38β2 (IC50=50/100 nM) selectively and cell-permeably. SB 202190 has antitumor activity and also ...
|
T6S1315 |
Oroxylin A
|
480-11-5
|
99.67%
|
|
1. Oroxylin A (Baicalein 6-methyl ether) has various anti-tumor effects including apoptosis, cell cycle arrest, drug-resistant reversion. 2. Oroxylin A possesses...
|
T6696 |
Tazarotene
|
118292-40-3
|
99.67%
|
|
Tazarotene (Zorac) is a synthetic, topical retinoid. Tazarotene induces the expression of tazarotene-induced gene 3 (TIG3), a tumor suppressor gene. In psoriasis...
|
T8399 |
Crizotinib hydrochloride
|
1415560-69-8
|
99.67%
|
|
Crizotinib hydrochloride (PF-02341066 hydrochloride) is a novel inhibitor of anaplastic lymphoma kinase and c-Met(IC50s of 20 and 8 nM)
|
T0450L |
Fluoxetine hydrochloride
|
56296-78-7
|
99.66%
|
|
Fluoxetine hydrochloride (Lilly110140) is the first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable s...
|